Latest news with #OramedPharmaceuticalsInc
San Francisco Chronicle
2 days ago
- Business
- San Francisco Chronicle
Oramed: Q2 Earnings Snapshot
NEW YORK (AP) — NEW YORK (AP) — Oramed Pharmaceuticals Inc. (ORMP) on Thursday reported net income of $13.3 million in its second quarter. On a per-share basis, the New York-based company said it had profit of 31 cents. Losses, adjusted for non-recurring gains, were 5 cents per share. _____
San Francisco Chronicle
15-05-2025
- Business
- San Francisco Chronicle
Oramed: Q1 Earnings Snapshot
NEW YORK (AP) — NEW YORK (AP) — Oramed Pharmaceuticals Inc. (ORMP) on Thursday reported a loss of $7.6 million in its first quarter. On a per-share basis, the New York-based company said it had a loss of 19 cents. The drug maker posted revenue of $2 million in the period. _____
Yahoo
15-05-2025
- Business
- Yahoo
Oramed: Q1 Earnings Snapshot
NEW YORK (AP) — NEW YORK (AP) — Oramed Pharmaceuticals Inc. (ORMP) on Thursday reported a loss of $7.6 million in its first quarter. On a per-share basis, the New York-based company said it had a loss of 19 cents. The drug maker posted revenue of $2 million in the period. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ORMP at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15-05-2025
- Business
- Yahoo
Oramed: Q1 Earnings Snapshot
NEW YORK (AP) — NEW YORK (AP) — Oramed Pharmaceuticals Inc. (ORMP) on Thursday reported a loss of $7.6 million in its first quarter. On a per-share basis, the New York-based company said it had a loss of 19 cents. The drug maker posted revenue of $2 million in the period. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ORMP at
